🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multicenter, single-arm, open-label study. The main ...
Status
Recruiting
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2023-10-18
Trial ID
NCT06389760
Treatments Being Tested
Pancreatic adenocarcinoma (PAAD) is a leading cause of cancer-related death...
Status
Recruiting
Location
Ruijing Hospital
Start Date
2025-06-01
Trial ID
NCT06966440
Treatments Being Tested
To determine if carbon ion radiotherapy improves overall survival versus ph...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center
Start Date
2019-05-29
Trial ID
NCT03536182
Treatments Being Tested
This is a research study to evaluate how the genetic makeup of Pancreatic D...
Status
Recruiting
Location
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
Start Date
2019-06-12
Trial ID
NCT03977233
Treatments Being Tested
This study is a multicenter, open-label, uncontrolled study to investigate ...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2021-01-13
Trial ID
NCT06538207
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and efficac...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2022-03-30
Trial ID
NCT05257993
Treatments Being Tested
This study will enroll patients who have metastatic pancreatic cancer with ...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2013-11
Trial ID
NCT01896869
Treatments Being Tested
Pancreatic adenocarcinoma (PDAC) constitutes 90% of pancreatic tumors and i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04
Trial ID
NCT06743386
Treatments Being Tested
The study aims to determine maximum tolerated dose (MTD) or recommended com...
Status
Active Not Recruiting
Location
Comprehensive Blood and Cancer Center
Start Date
2024-05-29
Trial ID
NCT06360354
Treatments Being Tested
This phase I trial studies the side effects and best dose of CPI-613 when g...
Status
Completed
Location
Comprehensive Cancer Center of Wake Forest University
Start Date
2013-04
Trial ID
NCT01835041